S0003734

EFV400mg+3TC300mg+TDF300mg tab/PAC-30


Efavirenz 400mg + Lamivudine 300mg + Tenofovir Disoproxil Fumarate 300mg, equivalent to 245mg Tenofovir Disoproxil 300mg, film coated tablets, bottle pack of 30 with or without outer carton. This product also comes in other pack sizes (90s, 180s).
Indicative Price 5.45 USD

General description:
Efavirenz 400mg + Lamivudine 300mg + Tenofovir Disoproxil Fumarate 300mg, equivalent to 245mg Tenofovir Disoproxil 300mg, film coated tablets, bottle pack of 30 with or without outer carton. This product also comes in other pack sizes (90s, 180s).

Technical Specifications
Each film coated tablet contains Efavirenz 400mg, Lamivudine 300mg and Tenofovir Disoproxil Fumarate 300 mg, equivalent to 245 mg Tenofovir Disoproxil as fixed dose combination.

Therapeutic class
Efavirenz is a Non Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Lamivudine is Nucleoside Reverse Transcriptase Inhibitors (NRTI)
Tenofovir is a Nucleotide Reverse Transcriptase Inhibitor (NtRTI)

Dosage, Instructions for use:
Please refer to the guideline WHO Model Formulary 2008:
http://apps.who.int/iris/bitstream/handle/10665/44053/9789241547659_eng. pdf?sequence=1
https://www.who.int/publications/i/item/9789241547659
For more details, please see WHO treatment guidelines https://www.who.int/publications/i/item/9789240031593 and WHO Essential Medicines Library https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02 or your regional/national guidelines.

Indications
Management of HIV-1 infection in children and adults in combination with at least two other antiretroviral drugs. By mouth (oral) PO.

Shelf life:
24 months

Storage conditions:
Do not store above 30°C.

Component of a KIT:
No

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.
Related Products